spectrila
medac gesellschaft fuer klinische spezialpraeparate mbh - asparaginase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - spectrila is indicated as a component of antineoplastic combination therapy for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years and adults.
aricept 5mg tablets
eisai ltd - donepezil hydrochloride - oral tablet - 5mg
aricept 10mg tablets
eisai ltd - donepezil hydrochloride - oral tablet - 10mg
aricept 5mg tablets
waymade healthcare plc - donepezil hydrochloride - oral tablet - 5mg
aricept 5mg tablets
dowelhurst ltd - donepezil hydrochloride - oral tablet - 5mg
aricept evess 5mg orodispersible tablets
eisai ltd - donepezil hydrochloride - orodispersible tablet - 5mg
aricept evess 10mg orodispersible tablets
eisai ltd - donepezil hydrochloride - orodispersible tablet - 10mg
aricept 5mg tablets
de pharmaceuticals - donepezil hydrochloride - oral tablet - 5mg
aricept 5mg tablets
sigma pharmaceuticals plc - donepezil hydrochloride - oral tablet - 5mg
aricept 5mg tablets
lexon (uk) ltd - donepezil hydrochloride - oral tablet - 5mg